C. O’Donnell

发表

Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis

T. Burke, G. Donohoe, E. O'callaghan, 2001, European Psychiatry.

Severity of alcohol dependence and its relationship to neurological soft signs, neuropsychological impairment and family history

C. O’Donnell, E. Keenan, K. Sinanan, 1997, Acta psychiatrica Scandinavica.

The International Study on General Practitioners and Early Psychosis (IGPS)

D. Umbricht, P. Amminger, A. Simon, 2009, Schizophrenia Research.

Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor in Quetiapine Treated First-Episode Psychosis

A. Hannan, P. McGorry, B. Murphy, 2014, Schizophrenia research and treatment.

Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.

H. Yuen, P. McGorry, B. Murphy, 2016, The Journal of clinical psychiatry.

The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B12, B6, and Folic Acid on Symptoms and Neurocognition in First-Episode Psychosis

P. Maruff, H. Yuen, P. McGorry, 2019, Biological Psychiatry.

The reliability and validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in first-episode psychosis.

P. McGorry, L. Hides, D. Lubman, 2009, Addictive behaviors.

Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.

S. Wood, H. Yuen, P. McGorry, 2008, The Journal of clinical psychiatry.

Compliance therapy: a randomised controlled trial in schizophrenia

G. Donohoe, E. O'callaghan, C. Larkin, 2003, BMJ : British Medical Journal.